Latest pharmaceutical industry Stories
Once-daily oral medication to be reimbursed for first-line use MISSISSAUGA, ON, May 25, 2015 /CNW/ - Genzyme, a Sanofi company, announced today that PEI Pharmacare has included
RnRMarketResearch.com adds "Arrhythmias - Pipeline Review, H1 2015" to its store.
THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Company has commenced termination of its participation in the co-development and commercialization
OTTAWA, May 22, 2015 /CNW/ - More than fifty years ago, Thalidomide was approved by Health Canada and prescribed to treat morning sickness in expectant mothers.
CHAPEL HILL, N.C., May 22, 2015 /PRNewswire/ -- Effective staffing of key marketing services functions is critical to pharmaceutical brand recognition and success. Research and consulting leader
Statistically Significant Findings Identify Key Efficacy Targets for Phase IIb/III Clinical Trial with RGN-259 ROCKVILLE, Md., May 22, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals,
DUBLIN, May 22, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/3rthk2/latest)
- Unanimous Recommendation to Grant European Marketing Authorization for Omidria Based on Benefit/Risk Profile - SEATTLE, May 22, 2015 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER),
SHANGHAI, May 21, 2015 /PRNewswire/ -- A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright
Following Approval of the First Biosimilar in the U.S., Physician Groups Urge FDA to Give Full Consideration to Inclusion of Critical Information Needed by Physicians WASHINGTON, May 21, 2015
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.